Effect of Ayurvedic Medicine in High BP

A Randomised standard controlled comparative clinical study to evaluate the adjuvant effect of Sarpagandha Mishrana along with conventional anti hypertensive therapy in the management of essential hypertension - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102121

Enrollment

Registered

2026-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient taking Amlodipine but not achieving desired results are included. 2.Patients diagnosed as Essential Hypertension as per diagnostic criteria. 3.Subjects willing and able to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Secondary Hypertension. 2.Patients with a prior diagnosis of severe or malignant hypertension, moderate hypertension associated with complications, cerebrovascular disorders, coronary artery diseases, kidney conditions, heart failure, cardiomyopathy, pre-eclampsia or eclampsia, diabetes mellitus, retinopathy, or any other coexisting physical or mental health condition.

Design outcomes

Primary

Measure	Time frame
High Blood pressure reduction to normal range according to ageTimepoint: 28 days	—

Secondary

Measure	Time frame
Reduction of High blood pressure to normal range & maintenance blood pressure within normal range with medicationTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Sanjay Kadlimatti

BLDEAS AVS Mahavidyala Hospital and research center

ayursanjay@gmail.com8970744656

Outcome results